Jump Financial, LLC Supernus Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$25.77 - $35.16 $870,252 - $1.19 Million	-33,770 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $877,682 - $1.14 Million	33,770 New	33,770 $903,000
Q2 2023 Oct 21, 2024	SELL	$29.91 - $38.73 $163,607 - $211,853	-5,470 Reduced 16.2%	28,300 $850,000
Q2 2023 Aug 07, 2023	BUY	$29.91 - $38.73 $846,453 - $1.1 Million	28,300 New	28,300 $850,000
Q4 2021 Feb 10, 2022	SELL	$26.37 - $34.22 $338,538 - $439,316	-12,838 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.54 - $31.39 $302,206 - $402,984	12,838 New	12,838 $342,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.